Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

586
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
586
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

520
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
520
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

688
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
688
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

685
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
685
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemopexin Purification From Human Cohn Fraction IV Paste and Its Biophysical Characterization and Functional Evaluation in Sickle Cell Disease Mice.

Biotechnology and bioengineering·2026
Same author

The resurgence of whole blood transfusion: Evaluating microcirculatory evidence in hemorrhagic trauma care: A review.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

Sex determines cardiac and renal Vulnerability to chronic hemoglobin toxicity.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Intermittent Hypoxia Associated with Sleep Apnea Disrupts Microvascular Hemodynamics and Oxygen Delivery.

Communications biology·2026
Same author

Modulatory effects of exogenous estradiol during endotoxemia.

The international journal of biochemistry & cell biology·2026
Same author

Scalable desolvation synthesis, storage stability, and comprehensive biophysical characterization of human hemoglobin nanoparticles as a potential hemoglobin-based oxygen carrier.

Biotechnology progress·2026

Related Experiment Video

Updated: Mar 6, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.3K

Acellular Hemoglobin Impairs Cardiomyocyte Excitation-Contraction Coupling.

Daniela Lucas1, Carlos Munoz1, Cynthia R Muller1

  • 1From the Shu Chien-Gene Lay Department of Bioengineering, University of California, San Diego, California.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|March 4, 2026
PubMed
Summary
This summary is machine-generated.

Acellular hemoglobin (Hb) and methemoglobin (MetHb) from red blood cell breakdown harm heart cells by disrupting calcium handling and increasing oxidative stress. While Hb polymerization and antioxidants offer some protection, multi-target strategies are needed for hemolytic disorders.

Keywords:
cardiomyocyte dysfunctionexcitation-contraction couplinghemoglobinhemolysisoxidative stress

More Related Videos

Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling
08:29

Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling

Published on: August 1, 2016

10.0K
Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

18.0K

Related Experiment Videos

Last Updated: Mar 6, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.3K
Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling
08:29

Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling

Published on: August 1, 2016

10.0K
Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

18.0K

Area of Science:

  • Cardiovascular Biology
  • Hematology
  • Toxicology

Background:

  • Chronic intravascular hemolysis leads to heart failure due to red blood cell breakdown.
  • Released acellular hemoglobin (Hb) and methemoglobin (MetHb) cause nitric oxide (NO) scavenging, oxidative stress, and inflammation.
  • Understanding Hb toxicity is crucial for managing hemolytic disorders and developing Hb-based oxygen carriers.

Purpose of the Study:

  • To investigate the direct impact of Hb and MetHb on cardiomyocyte function.
  • To assess the protective effects of Hb polymerization and antioxidant therapy against Hb-induced toxicity.
  • To elucidate the mechanisms underlying Hb-induced cardiomyocyte dysfunction.

Main Methods:

  • Cardiomyocyte function was assessed by measuring calcium transients and fractional shortening.
  • Reactive oxygen species (ROS) production was quantified.
  • The effects of polymerized Hb, NO scavenging inhibition, and N-acetylcysteine (NAC) were evaluated.

Main Results:

  • Acellular Hb and MetHb impaired cardiomyocyte function, prolonging calcium transient half-life and reducing contractility.
  • Increased ROS production was observed in cardiomyocytes exposed to Hb and MetHb.
  • Hb polymerization and NAC provided partial protection but did not fully reverse the toxic effects.

Conclusions:

  • Hb-induced cardiomyocyte dysfunction is multifactorial, involving NO scavenging, oxidative stress, and calcium dynamics disruption.
  • Current protective strategies like Hb polymerization and antioxidants offer limited efficacy.
  • Novel multi-target therapeutic approaches are necessary to combat Hb toxicity in hemolytic conditions.